Stocksigma LogoStocksigma Logo

Essix Biosciences Acquired 70 Lakh Warrants in Ind-Swift Laboratories

Promoter entity Essix Biosciences acquired 70,00,000 fully convertible warrants in Ind-Swift Laboratories on a preferential basis for cash on 17th Sep'26

Essix Biosciences Acquired 70 Lakh Warrants in Ind-Swift Laboratories

Ind-Swift Laboratories Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 11:41 pm

Essix Biosciences Acquired 70 Lakh Warrants in Ind-Swift Laboratories Promoter entity Essix Biosciences acquired 70,00,000 fully convertible warrants in Ind-Swift Laboratories on a preferential basis for cash on 17th Sep'26, representing 7.45% of diluted capital. Post-transaction, Essix Biosciences and persons acting in concert hold 3,73,34,278 equity shares (42.93% voting capital) and 70,00,000 warrants, raising their combined diluted stake from 43.06% to 47.18%. Following the preferential allotment and an ESOP exercise of 2,50,000 shares, the company's total diluted share capital stands at Rs. 93.96 crore, comprising 9,39,61,558 equity shares.

Original exchange filing (PDF)

More announcements from Ind-Swift Laboratories Ltd

All Ind-Swift Laboratories Ltd announcements